Compound ID | 764

Update compound information

Boxazomycin B

Class: Protein synthesis inhibitor (boxazomycin derivative)

Spectrum of activity: Gram-positive
Details of activity: The boxazomycin antibiotics demonstrate potent activity against anaerobes and Gram positives including S. pyogenes and S. aureus
Description: Song Y, Domagala JM, Turner WR, et al. Boxazomycin analogues as new antibacterial agents synthesis and structure-activity relationships. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 116.
Institute where first reported: Parke Davis Pharmaceutical Research (Pfizer, USA)
Year first mentioned: 1995
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 300.27
Iso. SMILES: CC1=CC(=C(C2=C1OC(=N2)C3=NC(=NC=C3O)C)C(=O)N)O
InChI Key: ILGGOCYCDJJADI-UHFFFAOYSA-N
Can. SMILES: CC1=C2C(=C(C(=C1)O)C(=O)N)N=C(C3=NC(=NC=C3O)C)O2
InChI: InChI=1S/C14H12N4O4/c1-5-3-7(19)9(13(15)21)11-12(5)22-14(18-11)10-8(20)4-16-6(2)17-10/h3-4,19-20H,1-2H3,(H2,15,21)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/135527050
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.